ROBYN OSTAPOW: Open Payments
NPI 1104819341 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 17 payments from 10 companies in 2025. Trend: 2023 $476 · 2024 $624 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $93 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| ABBVIE INC. | 2 | $48 |
| Exact Sciences Corporation | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $23 |
| PFIZER INC. | 1 | $17 |
| Lucid Diagnostics Inc. | 1 | $16 |
Products named: CAMZYOS, JARDIANCE, UBRELVY, Cologuard Collection Kit, ZEPBOUND, FARXIGA, M-M-R II, Rybelsus.
Industry payments across RI — which companies pay providers there.
